Additionally, silencing of UBE2M suppressed the growth of breast cancer cells by inducing cell cycle arrest and apoptosis (Fig. 4), thereby increasing the sensitivity of cancer cells to fulvestrant both in vitro and in vivo (Figs. 5 and 6). This evidence concerns the gene UBE2M and breast carcinoma.